Risk for Mortality Up With Low Income in Type 2 Diabetes
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 15, 2024 -- Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years, according to a study published online Nov. 12 in JAMA Network Open.
Ji Yoon Kim, M.D., Ph.D., from the Korea University College of Medicine in Seoul, and colleagues estimated the overall and cause-specific mortality risks among patients with T2D according to income and age in a retrospective nationwide cohort study involving 604,975 adults aged 20 to 79 years diagnosed with T2D between Jan. 1, 2008, and Dec. 31, 2013, who were followed until Dec. 31, 2019, and 635,805 age- and sex-matched controls without diabetes.
The researchers found that among patients with T2D, the risk for mortality increased with lower income overall and compared with controls without diabetes. An inverse association was seen between income and mortality risk among younger individuals (adjusted hazard ratios for all-cause mortality in the low- versus high-income subgroups, 2.88, 1.90, and 1.26 for those aged 20 to 39 years, 40 to 59 years, and 60 to 79 years, respectively). The pattern of income-related disparities among younger individuals was also seen for cardiovascular mortality, but less so for cancer mortality.
"Individual income level was an independent risk factor for mortality in patients with T2D, and the income-related disparity in mortality was pronounced in young people," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-16 12:00
Read more
- Globally, Suicide Risk Increased on Certain Days of the Week, Holidays
- Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
- Generic Medications Can Keep OOP Costs Down for Neurological Conditions
- Better Prepared Emergency Departments Could Save Children's Lives
- 1 in 5 Americans' Drinking Water Tainted With PFAS Chemicals
- ASN: Atrasentan Significantly and Clinically Meaningfully Cuts Proteinuria
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions